Similar articles

• DIANA trials on diet and endogenous hormones.

  Berrino F, Bellati C, Ooldani S, Mastroianni A, Allegro G, Berselli E, Venturelli E, Cavalleri A, Cambié M, Pala V, Pasanisi P, Secreto G. Berrino F, et al. IARC Sci Publ. 2002;156:439-44. IARC Sci Publ. 2002. PMID: 12484231 Clinical Trial. No abstract available.
• Elevated estradiol and testosterone levels and risk for breast cancer.

  Yu H, Diamandis EP, Hoffman B. Yu H, et al. Ann Intern Med. 1999 Nov 2;131(9):715. doi: 10.7326/0003-4819-131-9-199911020-00023. Ann Intern Med. 1999. PMID: 10577342 No abstract available.
• [Serum levels of prolactin, estradiol, testosterone and sex hormone-binding globulin in women with breast cancer treated with cytostatics and anti-estrogens].

  Grodecka-Gazdecka S, Baron J. Grodecka-Gazdecka S, et al. Ginekol Pol. 1986 Dec;57(12):778-83. Ginekol Pol. 1986. PMID: 3570023 Polish. No abstract available.
• The effect of tamoxifen and stilboestrol on plasma hormone levels in postmenopausal women with advanced breast cancer.

  McFadyen IJ, Raab G, Forrest AP, Langlands AO, Stewart HJ, Roberts MM, Hamilton T, Golder MP, Groom GV, Griffiths K. McFadyen IJ, et al. Clin Oncol. 1979 Sep;5(3):251-6. Clin Oncol. 1979. PMID: 387323 Clinical Trial. No abstract available.
• Hormones and breast cancer.

  Key TJ, Allen NE. Key TJ, et al. IARC Sci Publ. 2002;156:273-6. IARC Sci Publ. 2002. PMID: 12484186 Review. No abstract available.